Sepsis Diagnostics Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Sepsis Diagnostics Market to 2025 - Global Analysis and Forecasts by Product (Instruments, Reagents & Assays, Blood Culture Media and Software), Technology (Molecular Diagnostics, Flow Cytometry, Microfluidics, Immunoassay, Biomarkers and Microbiology), Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-Of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis and Other Pathogens), End User (Hospitals, Pathology & Reference Laboratories and Others) and Geography

Report Code: TIPHE100001391 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Sepsis is a systemic inflammatory response against the microbial infections, which can lead to organ dysfunction or failure. It is possible by pathogenic micro-organisms including bacterial, viral, fungal or parasitic organism that can easily enter the bloodstream. As a result, they can arise infection at a localized site of infection such as the lung or urogenital tract. On the other hand, the entry of microorganism in the blood stream is also possible via skin-breaks and also caused by surgery or the insertion of catheters during hospital treatment. In turn, systemic immune response take place that can cause severe symptoms including elevated heart rate and rapid breathing or severe fever. It is a potentially lethal condition that can leads directly to the death. In order to identify of causative agent, sepsis Diagnostics is performed. Sepsis occurs in a condition, when an immune system of the host responds to an infection, and then chemicals released to treat the infection.

The market for sepsis Diagnostics is expected to grow significantly in the coming years, owing to the key factors such as high incidence of hospital-acquired infections, increasing government initiatives for creating sepsis awareness and rising geriatric population across the globe. Moreover, increasing adoption of high-end sepsis diagnostics devices, increasing health care awareness and health care expenditure are likely to add novel opportunities for the global sepsis Diagnostics market over the forecast period.

The "Global Sepsis Diagnostics Market Analysis to 2025" is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global sepsis Diagnostics market with detailed market segmentation by product, technology, method, test type, pathogen, end user and geography. The global sepsis Diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

On the basis of product segment, the market is classified as instruments, reagents & assays, blood culture media and software. The technology market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers and microbiology. The sepsis Diagnostics market by method segment is bifurcated into automated diagnostics and conventional diagnostics. The test type segment is divided into point-of-care tests and laboratory tests. The pathogen segment is categorized into bacterial sepsis, fungal sepsis and other pathogens. Based on end user, the sepsis Diagnostics market is classified as hospitals, pathology & reference laboratories and others. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global sepsis Diagnostics market based on product, technology, method, test type, pathogen and end user. It also provides market size and forecast till 2025 for overall sepsis Diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to dominate the sepsis Diagnostics market in the global arena due to growing adoption of new and advanced diagnostic techniques, and increasing incidences of chronic diseases such as cancer or/and diabetes leading to increasing hospital admissions. However, the Asia-Pacific region is anticipated to show a significant growth rate over the next few years in the global sepsis Diagnostics market due to rising incidences of hospital acquired infections in the region.

The sepsis Diagnostics market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The sepsis Diagnostics market report also includes the profiles of sepsis Diagnostics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the sepsis Diagnostics market are Danaher, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., bioMérieux SA, T2 Biosystems, Inc., BD, Abbott, Luminex Corporation, Immunexpress, Axis-Shield Diagnostics Ltd. and among others.
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. SEPSIS DIAGNOSTICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Sepsis Diagnostics Market - By Product
3.2.2. Sepsis Diagnostics Market - By Technology
3.2.3. Sepsis Diagnostics Market - By Method
3.2.4. Sepsis Diagnostics Market - By Test Type
3.2.5. Sepsis Diagnostics Market - By Pathogen
3.2.6. Sepsis Diagnostics Market - By End User
3.2.7. Sepsis Diagnostics Market - By Region
3.2.7.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. SEPSIS DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. SEPSIS DIAGNOSTICS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL SEPSIS DIAGNOSTICS MARKET OVERVIEW
5.2. GLOBAL SEPSIS DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. INSTRUMENTS MARKET
6.3.1. Overview
6.3.2. Instruments Market Revenue Forecasts and Analysis (US$ Mn)
6.4. REAGENTS & ASSAYS MARKET
6.4.1. Overview
6.4.2. Reagents & Assays Market Revenue Forecasts and Analysis (US$ Mn)
6.5. BLOOD CULTURE MEDIA MARKET
6.5.1. Overview
6.5.2. Blood Culture Media Market Revenue Forecasts and Analysis (US$ Mn)
6.6. SOFTWARE MARKET
6.6.1. Overview
6.6.2. Software Market Revenue Forecasts and Analysis (US$ Mn)
7. SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. MOLECULAR DIAGNOSTICS MARKET
7.3.1. Overview
7.3.2. Molecular Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3. Polymerase Chain Reaction Market
7.3.3.1. Overview
7.3.3.2. Polymerase Chain Reaction Market Revenue Forecasts and Analysis (US$ Mn)
?
7.3.4. Peptide Nucleic Acid-Fluorescent in Situ Hybridization Market
7.3.4.1. Overview
7.3.4.2. Peptide Nucleic Acid-Fluorescent in Situ Hybridization Market Revenue Forecasts and Analysis (US$ Mn)
7.3.5. Syndromic Panel-Based Testing Market
7.3.5.1. Overview
7.3.5.2. Syndromic Panel-Based Testing Market Revenue Forecasts and Analysis (US$ Mn)
7.3.6. Microarrays Market
7.3.6.1. Overview
7.3.6.2. Microarrays Market Revenue Forecasts and Analysis (US$ Mn)
7.4. FLOW CYTOMETRY MARKET
7.4.1. Overview
7.4.2. Flow Cytometry Market Revenue Forecasts and Analysis (US$ Mn)
7.5. MICROFLUIDICS MARKET
7.5.1. Overview
7.5.2. Microfluidics Market Revenue Forecasts and Analysis (US$ Mn)
7.6. IMMUNOASSAY MARKET
7.6.1. Overview
7.6.2. Immunoassay Market Revenue Forecasts and Analysis (US$ Mn)
7.7. BIOMARKERS MARKET
7.7.1. Overview
7.7.2. Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
7.8. MICROBIOLOGY MARKET
7.8.1. Overview
7.8.2. Microbiology Market Revenue Forecasts and Analysis (US$ Mn)
8. SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY METHOD
8.1. OVERVIEW
8.2. METHOD MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. AUTOMATED DIAGNOSTICS MARKET
8.3.1. Overview
8.3.2. Automated Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
8.4. CONVENTIONAL DIAGNOSTICS MARKET
8.4.1. Overview
8.4.2. Conventional Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
9. SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY TEST TYPE
9.1. OVERVIEW
9.2. TEST TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. POINT-OF-CARE TESTS MARKET
9.3.1. Overview
9.3.2. Point-Of-Care Tests Market Revenue Forecasts and Analysis (US$ Mn)
9.4. LABORATORY TESTS MARKET
9.4.1. Overview
9.4.2. Laboratory Tests Market Revenue Forecasts and Analysis (US$ Mn)
10. SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY PATHOGEN
10.1. OVERVIEW
10.2. PATHOGEN MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
10.3. BACTERIAL SEPSIS MARKET
10.3.1. Overview
10.3.2. Bacterial Sepsis Market Revenue Forecasts and Analysis (US$ Mn)
10.4. FUNGAL SEPSIS MARKET
10.4.1. Overview
10.4.2. Fungal Sepsis Market Revenue Forecasts and Analysis (US$ Mn)
10.5. OTHER PATHOGENS MARKET
10.5.1. Overview
10.5.2. Other Pathogens Market Revenue Forecasts and Analysis (US$ Mn)
11. SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
11.1. OVERVIEW
11.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
11.3. HOSPITALS MARKET
11.3.1. Overview
11.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
11.4. PATHOLOGY & REFERENCE LABORATORIES MARKET
11.4.1. Overview
11.4.2. Pathology & Reference Laboratories Market Revenue Forecasts and Analysis (US$ Mn)
11.5. OTHER END USER MARKET
11.5.1. Overview
11.5.2. Other End User Market Revenue Forecasts and Analysis (US$ Mn)
12. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET OVERVIEW
12.2. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.5. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY METHOD (US$ MN)
12.6. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST TYPE (US$ MN)
12.7. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PATHOGEN (US$ MN)
12.7.1. North America Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.8. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.9. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.10. US MARKET OVERVIEW
12.10.1. US Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
12.10.2. US Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
12.10.3. US Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
12.10.4. US Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
12.10.5. US Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
12.10.5.1. US Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.10.6. US Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.11. CANADA MARKET OVERVIEW
12.11.1. Canada Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
12.11.2. Canada Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
12.11.3. Canada Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
12.11.4. Canada Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
12.11.5. Canada Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
12.11.5.1. Canada Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.11.6. Canada Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.12. MEXICO MARKET OVERVIEW
12.12.1. Mexico Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
12.12.2. Mexico Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
12.12.3. Mexico Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
12.12.4. Mexico Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
12.12.5. Mexico Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
12.12.5.1. Mexico Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.12.6. Mexico Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. EUROPE SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. EUROPE SEPSIS DIAGNOSTICS MARKET OVERVIEW
13.2. EUROPE SEPSIS DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. EUROPE SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.4. EUROPE SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.5. EUROPE SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY METHOD (US$ MN)
13.6. EUROPE SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST TYPE (US$ MN)
13.7. EUROPE SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PATHOGEN (US$ MN)
13.7.1. EUROPE Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.8. EUROPE SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.9. EUROPE SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.10. UK MARKET OVERVIEW
13.10.1. UK Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
13.10.2. UK Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
13.10.3. UK Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
13.10.4. UK Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
13.10.5. UK Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
13.10.5.1. UK Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.10.6. UK Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.11. GERMANY MARKET OVERVIEW
13.11.1. Germany Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
13.11.2. Germany Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
13.11.3. Germany Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
13.11.4. Germany Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
13.11.5. Germany Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
13.11.5.1. Germany Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.11.6. Germany Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
14.1. ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET OVERVIEW
14.2. ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
14.4. ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
14.5. ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY METHOD (US$ MN)
14.6. ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST TYPE (US$ MN)
14.7. ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PATHOGEN (US$ MN)
14.7.1. ASIA PACIFIC Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
14.8. ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
14.9. ASIA PACIFIC SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
14.10. JAPAN MARKET OVERVIEW
14.10.1. Japan Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
14.10.2. Japan Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
14.10.3. Japan Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
14.10.4. Japan Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
14.10.5. Japan Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
14.10.5.1. Japan Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
14.10.6. Japan Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14.11. CHINA MARKET OVERVIEW
14.11.1. China Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
14.11.2. China Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
14.11.3. China Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
14.11.4. China Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
14.11.5. China Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
14.11.5.1. China Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
14.11.6. China Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14.12. INDIA MARKET OVERVIEW
14.12.1. India Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
14.12.2. India Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
14.12.3. India Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
14.12.4. India Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
14.12.5. India Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
14.12.5.1. India Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
14.12.6. India Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
15. MIDDLE EAST AND AFRICA (MEA) SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
15.1. MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET OVERVIEW
15.2. MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
15.3. MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
15.4. MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
15.5. MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY METHOD (US$ MN)
15.6. MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST TYPE (US$ MN)
15.7. MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PATHOGEN (US$ MN)
15.7.1. Middle East And Africa Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
15.8. MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
15.9. MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
15.10. SOUTH AFRICA MARKET OVERVIEW
15.10.1. South Africa Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
15.10.2. South Africa Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
15.10.3. South Africa Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
15.10.4. South Africa Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
15.10.5. South Africa Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
15.10.5.1. South Africa Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
15.10.6. South Africa Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
15.11. SAUDI ARABIA MARKET OVERVIEW
15.11.1. Saudi Arabia Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
15.11.2. Saudi Arabia Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
15.11.3. Saudi Arabia Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
15.11.4. Saudi Arabia Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
15.11.5. Saudi Arabia Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
15.11.5.1. Saudi Arabia Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
15.11.6. Saudi Arabia Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
15.12. UAE MARKET OVERVIEW
15.12.1. UAE Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
15.12.2. UAE Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
15.12.3. UAE Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
15.12.4. UAE Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
15.12.5. UAE Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
15.12.5.1. UAE Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
15.12.6. UAE Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
16. SOUTH AND CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
16.1. SOUTH AND CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET OVERVIEW
16.2. SOUTH AND CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
16.3. SOUTH AND CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
16.4. SOUTH AND CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
16.5. SOUTH AND CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY METHOD (US$ MN)
16.6. SOUTH AND CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST TYPE (US$ MN)
16.7. SOUTH AND CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PATHOGEN (US$ MN)
16.7.1. South And Central America Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
16.8. SOUTH AND CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
16.9. SOUTH AND CENTRAL AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
16.10. BRAZIL MARKET OVERVIEW
16.10.1. Brazil Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Product (US$ Mn)
16.10.2. Brazil Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
16.10.3. Brazil Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Method (US$ Mn)
16.10.4. Brazil Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
16.10.5. Brazil Sepsis Diagnostics Market Revenue and Forecasts Analysis - By Pathogen (US$ Mn)
16.10.5.1. Brazil Bacterial Sepsis Market Revenue and Forecasts Analysis - By Type (US$ Mn)
16.10.6. Brazil Sepsis Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
17. INDUSTRY LANDSCAPE
17.1. ORGANIC GROWTH STRATEGIES
17.1.1. New Product Launches
17.1.2. Marketing & Promotional Activities
17.2. INORGANIC GROWTH STRATEGIES
17.2.1. Partnerships, Collaborations, and Joint Ventures
17.2.2. Mergers & Acquisitions
18. SEPSIS DIAGNOSTICS MARKET, KEY COMPANY PROFILES
18.1. DANAHER
18.1.1. Key Facts
18.1.2. Business Description
18.1.3. Financial Overview
18.1.4. Product Portfolio
18.1.5. Product Pipeline
18.1.6. SWOT Analysis
18.1.7. Key Developments
18.2. F. HOFFMANN-LA ROCHE LTD
18.2.1. Key Facts
18.2.2. Business Description
18.2.3. Financial Overview
18.2.4. Product Portfolio
18.2.5. Product Pipeline
18.2.6. SWOT Analysis
18.2.7. Key Developments
18.3. THERMO FISHER SCIENTIFIC INC.
18.3.1. Key Facts
18.3.2. Business Description
18.3.3. Financial Overview
18.3.4. Product Portfolio
18.3.5. Product Portfolio
18.3.6. SWOT Analysis
18.3.7. Key Developments
18.4. BIOMÉRIEUX SA
18.4.1. Key Facts
18.4.2. Business Description
18.4.3. Financial Overview
18.4.4. Product Portfolio
18.4.5. Product Pipeline
18.4.6. SWOT Analysis
18.4.7. Key Developments
18.5. T2 BIOSYSTEMS, INC.
18.5.1. Key Facts
18.5.2. Business Description
18.5.3. Financial Overview
18.5.4. Product Portfolio
18.5.5. Product Portfolio
18.5.6. SWOT Analysis
18.5.7. Key Developments
18.6. BD
18.6.1. Key Facts
18.6.2. Business Description
18.6.3. Financial Overview
18.6.4. Product Portfolio
18.6.5. Product Pipeline
18.6.6. SWOT Analysis
18.6.7. Key Developments
18.7. ABBOTT
18.7.1. Key Facts
18.7.2. Business Description
18.7.3. Financial Overview
18.7.4. Product Portfolio
18.7.5. Product Pipeline
18.7.6. SWOT Analysis
18.7.7. Key Developments
18.8. LUMINEX CORPORATION
18.8.1. Key Facts
18.8.2. Business Description
18.8.3. Financial Overview
18.8.4. Product Portfolio
18.8.5. Product Pipeline
18.8.6. SWOT Analysis
18.8.7. Key Developments
18.9. IMMUNEXPRESS
18.9.1. Key Facts
18.9.2. Business Description
18.9.3. Financial Overview
18.9.4. Product Portfolio
18.9.5. Product Pipeline
18.9.6. SWOT Analysis
18.9.7. Key Developments
18.10. AXIS-SHIELD DIAGNOSTICS LTD.
18.10.1. Key Facts
18.10.2. Business Description
18.10.3. Financial Overview
18.10.4. Product Portfolio
18.10.5. Product Pipeline
18.10.6. SWOT Analysis
18.10.7. Key Developments
19. APPENDIX
19.1. ABOUT THE INSIGHT PARTNERS
19.2. GLOSSARY OF TERMS
19.3. RESEARCH METHODOLOGY
The List of Companies

1. Danaher
2. F. Hoffmann-La Roche Ltd
3. Thermo Fisher Scientific Inc.
4. bioMérieux SA
5. T2 Biosystems, Inc.
6. BD
7. Abbott
8. Luminex Corporation
9. Immunexpress
10. Axis-Shield Diagnostics Ltd.

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book